

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1494, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Aspirin worthwhile as primary CVD prevention in hypertension
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :


Primary prevention of CVD with aspirin cost saving in Italy
Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. :


Aspirin not worth risks for primary CVD prevention
Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. :


GPs should recommend primary prevention with aspirin
Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. :